Next up in hunt for COVID-19 vaccine: Testing shots in kids
The global hunt for a COVID-19 vaccine for kids is only just beginning — a lagging start that has some U.S. pediatricians worried they may not know if any shots work for young children in time for the next school year.
Observed COVID-19 variability may have underlying molecular sources
People have different susceptibilities to SARS-CoV-2, the virus behind the COVID-19 pandemic, and develop varying degrees of fever, fatigue, and breathing problems -- common symptoms of the illness. What might explain this variation?
Why Getting a Flu Shot Makes Sense
COVID-19 may be grabbing most of the headlines, but flu season has arrived as well, and unlike the novel coronavirus, there are safe and effective vaccines to reduce the risk of flu.
Study Finds Significant Link Between Air Pollution and Neurological Disorders
Air pollution was significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson’s disease, Alzheimer’s disease, and other dementias, in a long-term study of more than 63 million older U.S. adults. The research was conducted by Harvard T.H. Chan School of Public Health, and colleagues at Columbia University Mailman School of Public Health, and Emory University’s Rollins School of Public Health.
Premiums for HealthCare.gov Plans Are Lower for Third Consecutive Year
On Monday, the Centers for Medicare & Medicaid Services (CMS) released a report showing the trend of lower premiums and increased issuer participation for HealthCare.gov will continue for 2021 year. The average premium for the second lowest cost silver plan (also called the benchmark plan) dropped by 2% for the 2021 coverage year and, when looking at states that are using HealthCare.gov in both 2020 and 2021, 22 more issuers will offer coverage in 2021, for a total of 181 issuers delivering more choice and competition for consumers.
